Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic ...

The new tool could help predict obesity-related health risks earlier and reshape prevention strategies, researchers say. The post MGB researchers just developed a new risk calculator for obesity. Here ...

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...

Clinical decision support tools have become a mainstay in many hospitals, helping clinicians identify early signs of serious conditions, flag potential deterioration and minimize medical errors. But ...

Survival models using EHR data predicted progression from NPDR or DME to PDR in type 2 diabetes patients. Key risk factors for progression included age, race, NPDR severity, and diabetic nephropathy.

Loneliness in chronic care patients leads to nonadherence, increased healthcare costs, and worsened health outcomes, highlighting its impact on both mental and physical health. Surveyed patients ...

Impact of COVID-19 infection on CAR-T therapy outcomes. Patterns of confirmatory germline testing in patients with somatic BRCA1/2 pathogenic variants across solid tumor types in a community oncology ...

SAN DIEGO--(BUSINESS WIRE)--Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the first commercially available clinical polygenic ...

A new study identifying 56 non-clinical risk factors associated with sudden cardiac arrest (SCA), spanning lifestyle, physical measures, psychosocial factors, socioeconomic status, and the local ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR™ (sotatercept ...